INmune Bio Inc. (NASDAQ: INMB)
$9.23
-0.6300 ( -6.39% ) 51.4K
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.
Market Data
Open
$9.23
Previous close
$9.86
Volume
51.4K
Market cap
$182.59M
Day range
$9.15 - $9.89
52 week range
$6.50 - $14.74
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 13 | Jul 05, 2024 |
| 8-k | 8K-related | 14 | Jul 01, 2024 |
| 4 | Insider transactions | 1 | Jun 26, 2024 |
| 8-k | 8K-related | 14 | Jun 13, 2024 |
| 4 | Insider transactions | 1 | Jun 12, 2024 |
| 8-k | 8K-related | 14 | May 30, 2024 |
| def | Proxies and info statements | 4 | May 29, 2024 |
| 8-k | 8K-related | 14 | May 23, 2024 |
| 4 | Insider transactions | 1 | May 16, 2024 |
| 4 | Insider transactions | 1 | May 16, 2024 |